MAPK Pathway as Potential Therapeutic Target in Clinical Neuro-oncology Given the frequent BRAF alterations in low-grade gliomas and glioneuronal tumors, there is considerable interest in targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback